These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3696316)

  • 1. Red-cell calcium in patients with renal failure.
    Barton IK; Mansell MA; Grimes AJ
    Nephron; 1987; 47(2):123-4. PubMed ID: 3696316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of Ca and Mg concentrations in plasma and erythrocytes during hemodialysis].
    Paschen K; Henning HV; Quellhorst E; Scheler F
    Klin Wochenschr; 1971 Dec; 49(24):1314-8. PubMed ID: 5138341
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of low magnesium dialysate on plasma, ultrafiltrable, erythrocyte and bone magnesium concentrations from patients on maintenance haemodialysis.
    Catto GR; Reid IW; MacLeod M
    Nephron; 1974; 13(5):372-81. PubMed ID: 4431548
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between the magnesium concentration in the dialysis fluid used and in the plasma and erythrocytes of patients with chronic renal failure being treated by regular haemodialysis.
    Heierli C; Hill AV
    Clin Sci; 1972 Dec; 43(6):779-87. PubMed ID: 4646274
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnesium, calcium and trace elements distribution in serum, erythrocytes, and hair of patients with chronic renal failure.
    Długaszek M; Szopa M; Rzeszotarski J; Karbowiak P
    Magnes Res; 2008 Jun; 21(2):109-17. PubMed ID: 18705539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of haemodialysis of erythrocyte and plasma potassium, magnesium, sodium and calcium.
    Johny KV; Lawrence JR; O'Halloran MW; Wellby ML
    Nephron; 1971; 8(1):81-90. PubMed ID: 5155602
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood and urinary cadmium in chronic renal failure.
    Willden EG; Hyne BE
    Nephron; 1974; 13(3):253-7. PubMed ID: 4418784
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythrocyte calcium in chronic renal failure.
    Udden MM
    Nephron; 1989; 51(4):573-4. PubMed ID: 2739842
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnesium status in chronic uraemic patients.
    Lim P; Jacob E
    Nephron; 1972; 9(5):300-7. PubMed ID: 4661673
    [No Abstract]   [Full Text] [Related]  

  • 10. Red blood cell calcium homeostasis in patients with end-stage renal disease.
    Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
    J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the factor which has an influence on red blood cell deformability in patients with end-stage renal disease].
    Tateishi K; Fujita J; Taminato T
    Rinsho Byori; 2009 Oct; 57(10):965-70. PubMed ID: 19928493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood, red cell and plasma total and ultrafiltrable zinc levels in normal subjects and patients with chronic renal failure with and without haemodialysis.
    Rose GA; Willden EG
    Br J Urol; 1972 Jun; 44(3):281-6. PubMed ID: 5039759
    [No Abstract]   [Full Text] [Related]  

  • 13. Trace element concentrations in hair, fingernails and plasma of patients with chronic renal failure on hemodialysis and hemofiltration.
    Marumo F; Tsukamoto Y; Iwanami S; Kishimoto T; Yamagami S
    Nephron; 1984; 38(4):267-72. PubMed ID: 6514076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc in plasma and red blood cells of children with chronic renal failure.
    López-Uriarte A; Ramos-Contreras P; Díaz-Bensussen S; López-Montaño E; Vargas-Rosendo R
    Arch Invest Med (Mex); 1984; 15(1):45-54. PubMed ID: 6477025
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.
    Lippuner K; Zehnder HJ; Casez JP; Takkinen R; Descoeudres C; Jaeger P
    Nephrol Dial Transplant; 1996 Jan; 11(1):70-4. PubMed ID: 8649655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vitamin E and fatty acid composition of the red cell membrane phospholipids in patients with chronic renal failure treated by hemodialysis.
    Heldenberg D; Blum M; Levtow O; Maisner I
    Clin Nephrol; 1982 Nov; 18(5):272. PubMed ID: 7151344
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I; Bladek K; Bulikowski W
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sodium and potassium content of erythrocytes at the terminal stage of chronic renal insufficiency and during treatment by chronic hemodialysis].
    Terekhov NT; Goligorskiĭ MS; Kremen' MG; Vasilenko VK
    Urol Nefrol (Mosk); 1974; (6):10-4. PubMed ID: 4141153
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of polyamines in plasma and erythrocytes of patients with chronic renal failure].
    Saito A; Takagi T; Chung TG
    Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):183-8. PubMed ID: 4021183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.